Concepts (281)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Citrulline | 10 | 2025 | 123 | 2.610 |
Why?
|
| Arginine | 9 | 2025 | 336 | 2.300 |
Why?
|
| Lactation | 9 | 2020 | 195 | 2.160 |
Why?
|
| Milk, Human | 10 | 2025 | 318 | 1.990 |
Why?
|
| Mammary Glands, Human | 4 | 2015 | 79 | 1.270 |
Why?
|
| Polyethylene Glycols | 3 | 2024 | 232 | 0.820 |
Why?
|
| Arginase | 2 | 2020 | 34 | 0.780 |
Why?
|
| Amino Acids | 3 | 2025 | 563 | 0.780 |
Why?
|
| Galactose | 2 | 2015 | 53 | 0.770 |
Why?
|
| Hydrolases | 3 | 2024 | 61 | 0.740 |
Why?
|
| Swine | 10 | 2025 | 1184 | 0.710 |
Why?
|
| Glutamine | 3 | 2024 | 201 | 0.660 |
Why?
|
| Gene Expression Regulation, Enzymologic | 2 | 2020 | 242 | 0.640 |
Why?
|
| Glucose | 5 | 2015 | 851 | 0.630 |
Why?
|
| Jejunum | 1 | 2020 | 123 | 0.620 |
Why?
|
| Duodenum | 1 | 2020 | 111 | 0.620 |
Why?
|
| Gluconeogenesis | 3 | 2015 | 93 | 0.570 |
Why?
|
| Nutrigenomics | 1 | 2017 | 7 | 0.540 |
Why?
|
| Glycerol | 2 | 2015 | 78 | 0.510 |
Why?
|
| Gastrointestinal Tract | 1 | 2018 | 210 | 0.490 |
Why?
|
| Aging | 2 | 2024 | 1236 | 0.490 |
Why?
|
| Lactose | 2 | 2020 | 55 | 0.480 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2020 | 951 | 0.480 |
Why?
|
| Blood Glucose | 5 | 2024 | 1108 | 0.470 |
Why?
|
| Intestinal Mucosa | 1 | 2020 | 762 | 0.460 |
Why?
|
| Lipids | 3 | 2013 | 559 | 0.440 |
Why?
|
| Lipogenesis | 2 | 2021 | 61 | 0.440 |
Why?
|
| Metabolic Networks and Pathways | 3 | 2018 | 192 | 0.390 |
Why?
|
| Lipid Metabolism | 2 | 2020 | 371 | 0.390 |
Why?
|
| Triglycerides | 3 | 2019 | 601 | 0.390 |
Why?
|
| MicroRNAs | 2 | 2017 | 882 | 0.390 |
Why?
|
| Dietary Carbohydrates | 2 | 2014 | 105 | 0.380 |
Why?
|
| Uridine Diphosphate Galactose | 1 | 2012 | 6 | 0.370 |
Why?
|
| Fasting | 2 | 2014 | 304 | 0.360 |
Why?
|
| Animals, Newborn | 5 | 2025 | 1018 | 0.360 |
Why?
|
| Female | 29 | 2025 | 70258 | 0.350 |
Why?
|
| Animals | 22 | 2025 | 33673 | 0.340 |
Why?
|
| Oligosaccharides | 2 | 2022 | 72 | 0.340 |
Why?
|
| Insulin | 3 | 2010 | 1143 | 0.330 |
Why?
|
| Diabetes, Gestational | 1 | 2012 | 111 | 0.330 |
Why?
|
| Dietary Sucrose | 1 | 2010 | 41 | 0.330 |
Why?
|
| Epithelial Cells | 2 | 2020 | 905 | 0.320 |
Why?
|
| Enteral Nutrition | 2 | 2025 | 286 | 0.310 |
Why?
|
| Breast Feeding | 3 | 2020 | 234 | 0.310 |
Why?
|
| Gene Expression Regulation | 3 | 2014 | 2323 | 0.290 |
Why?
|
| Premature Birth | 2 | 2025 | 420 | 0.280 |
Why?
|
| Cholestasis | 2 | 2021 | 170 | 0.280 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2024 | 1448 | 0.280 |
Why?
|
| Insulin Resistance | 3 | 2024 | 685 | 0.280 |
Why?
|
| Caloric Restriction | 1 | 2009 | 106 | 0.280 |
Why?
|
| Dietary Fats | 1 | 2009 | 275 | 0.260 |
Why?
|
| Mice, Inbred C57BL | 6 | 2024 | 4691 | 0.260 |
Why?
|
| Lactobacillus acidophilus | 1 | 2006 | 2 | 0.250 |
Why?
|
| Methylmalonic Acid | 1 | 2006 | 15 | 0.250 |
Why?
|
| Vitamin B 12 | 1 | 2006 | 59 | 0.240 |
Why?
|
| Neuroblastoma | 2 | 2022 | 547 | 0.240 |
Why?
|
| Homocysteine | 1 | 2006 | 116 | 0.240 |
Why?
|
| Growth Disorders | 1 | 2007 | 181 | 0.240 |
Why?
|
| Probiotics | 2 | 2020 | 226 | 0.240 |
Why?
|
| Fatty Acids | 2 | 2022 | 372 | 0.230 |
Why?
|
| Social Class | 1 | 2007 | 212 | 0.230 |
Why?
|
| Infusions, Intravenous | 2 | 2018 | 532 | 0.230 |
Why?
|
| Dietary Supplements | 2 | 2025 | 445 | 0.230 |
Why?
|
| Weight Loss | 1 | 2009 | 534 | 0.220 |
Why?
|
| Male | 16 | 2024 | 64392 | 0.220 |
Why?
|
| Obesity | 3 | 2024 | 2394 | 0.220 |
Why?
|
| Population Surveillance | 1 | 2007 | 393 | 0.220 |
Why?
|
| Receptors, Adrenergic, beta-3 | 1 | 2024 | 14 | 0.220 |
Why?
|
| N-Myc Proto-Oncogene Protein | 2 | 2022 | 57 | 0.210 |
Why?
|
| Folic Acid | 1 | 2006 | 269 | 0.210 |
Why?
|
| Kinetics | 2 | 2021 | 1085 | 0.210 |
Why?
|
| Thermogenesis | 1 | 2024 | 56 | 0.210 |
Why?
|
| Carbon Isotopes | 2 | 2015 | 227 | 0.210 |
Why?
|
| Adipose Tissue, Brown | 1 | 2024 | 89 | 0.210 |
Why?
|
| Endotoxemia | 1 | 2024 | 54 | 0.200 |
Why?
|
| Adult | 11 | 2024 | 31022 | 0.200 |
Why?
|
| Adipose Tissue, White | 1 | 2024 | 97 | 0.200 |
Why?
|
| Energy Metabolism | 2 | 2024 | 802 | 0.200 |
Why?
|
| Biological Availability | 2 | 2021 | 136 | 0.200 |
Why?
|
| Parenteral Nutrition | 3 | 2021 | 219 | 0.200 |
Why?
|
| Kidney | 2 | 2019 | 1279 | 0.190 |
Why?
|
| Enterocolitis, Necrotizing | 1 | 2025 | 257 | 0.180 |
Why?
|
| Glycomics | 1 | 2021 | 15 | 0.170 |
Why?
|
| Nuclear Receptor Subfamily 1, Group F, Member 1 | 1 | 2021 | 17 | 0.170 |
Why?
|
| Biosynthetic Pathways | 1 | 2021 | 31 | 0.170 |
Why?
|
| Phytosterols | 1 | 2021 | 28 | 0.170 |
Why?
|
| Gene Expression Profiling | 4 | 2017 | 1803 | 0.170 |
Why?
|
| Humans | 25 | 2025 | 130104 | 0.170 |
Why?
|
| Propane | 1 | 2020 | 28 | 0.160 |
Why?
|
| Disease Models, Animal | 4 | 2025 | 4643 | 0.160 |
Why?
|
| Glyceraldehyde | 1 | 2020 | 28 | 0.160 |
Why?
|
| Polysaccharides | 1 | 2021 | 146 | 0.160 |
Why?
|
| Urea Cycle Disorders, Inborn | 2 | 2020 | 83 | 0.160 |
Why?
|
| Tissue Distribution | 1 | 2021 | 362 | 0.160 |
Why?
|
| Liver Glycogen | 1 | 2020 | 21 | 0.160 |
Why?
|
| Diet | 3 | 2020 | 1097 | 0.150 |
Why?
|
| Metagenome | 1 | 2020 | 138 | 0.150 |
Why?
|
| Argininosuccinate Lyase | 1 | 2020 | 61 | 0.150 |
Why?
|
| Muscle, Skeletal | 1 | 2025 | 979 | 0.150 |
Why?
|
| Synbiotics | 1 | 2019 | 5 | 0.150 |
Why?
|
| Nitrogen Isotopes | 1 | 2018 | 45 | 0.140 |
Why?
|
| Docosahexaenoic Acids | 1 | 2019 | 67 | 0.140 |
Why?
|
| Ornithine Carbamoyltransferase | 1 | 2018 | 23 | 0.140 |
Why?
|
| Dipeptides | 1 | 2018 | 60 | 0.140 |
Why?
|
| Intestinal Diseases | 1 | 2019 | 67 | 0.140 |
Why?
|
| Oxidation-Reduction | 2 | 2009 | 434 | 0.140 |
Why?
|
| Endotoxins | 1 | 2018 | 50 | 0.140 |
Why?
|
| Liver Diseases, Alcoholic | 1 | 2019 | 62 | 0.140 |
Why?
|
| Microbiota | 2 | 2020 | 438 | 0.140 |
Why?
|
| Bile Acids and Salts | 1 | 2020 | 260 | 0.130 |
Why?
|
| Helicobacter pylori | 1 | 2007 | 1371 | 0.130 |
Why?
|
| Reactive Oxygen Species | 1 | 2020 | 526 | 0.130 |
Why?
|
| Helicobacter Infections | 1 | 2007 | 1311 | 0.130 |
Why?
|
| Benzoates | 1 | 2017 | 24 | 0.130 |
Why?
|
| Mice | 8 | 2024 | 18157 | 0.130 |
Why?
|
| Ethanol | 1 | 2019 | 168 | 0.130 |
Why?
|
| Lactic Acid | 2 | 2015 | 145 | 0.130 |
Why?
|
| Egypt | 2 | 2007 | 30 | 0.130 |
Why?
|
| Biological Transport | 2 | 2021 | 328 | 0.130 |
Why?
|
| Phenylbutyrates | 1 | 2017 | 54 | 0.130 |
Why?
|
| Mice, Knockout | 3 | 2020 | 3810 | 0.130 |
Why?
|
| Growth | 1 | 2017 | 93 | 0.130 |
Why?
|
| Models, Animal | 1 | 2018 | 450 | 0.120 |
Why?
|
| Nutritional Requirements | 1 | 2017 | 160 | 0.120 |
Why?
|
| Transcriptome | 2 | 2014 | 1103 | 0.120 |
Why?
|
| Cross-Over Studies | 2 | 2020 | 240 | 0.120 |
Why?
|
| Liver Diseases | 1 | 2020 | 378 | 0.120 |
Why?
|
| Sex Characteristics | 1 | 2017 | 321 | 0.110 |
Why?
|
| Fatty Acid-Binding Proteins | 1 | 2015 | 37 | 0.110 |
Why?
|
| Sodium Acetate | 1 | 2015 | 2 | 0.110 |
Why?
|
| Nitric Oxide | 1 | 2018 | 466 | 0.110 |
Why?
|
| Pentose Phosphate Pathway | 1 | 2015 | 43 | 0.110 |
Why?
|
| Isotope Labeling | 2 | 2018 | 95 | 0.110 |
Why?
|
| Genotype | 1 | 2020 | 2587 | 0.110 |
Why?
|
| Signal Transduction | 2 | 2025 | 4651 | 0.110 |
Why?
|
| Intestines | 1 | 2018 | 587 | 0.100 |
Why?
|
| Genes, Lethal | 1 | 2014 | 71 | 0.100 |
Why?
|
| Pyruvate Kinase | 1 | 2014 | 11 | 0.100 |
Why?
|
| Blood Chemical Analysis | 1 | 2014 | 80 | 0.100 |
Why?
|
| Infant, Premature | 1 | 2019 | 861 | 0.100 |
Why?
|
| Research Design | 1 | 2017 | 711 | 0.100 |
Why?
|
| Pulmonary Alveoli | 1 | 2014 | 140 | 0.100 |
Why?
|
| Fatty Liver | 1 | 2015 | 221 | 0.100 |
Why?
|
| Persistent Fetal Circulation Syndrome | 1 | 2014 | 86 | 0.100 |
Why?
|
| Pregnancy | 3 | 2019 | 7393 | 0.090 |
Why?
|
| Metabolism | 1 | 2012 | 45 | 0.090 |
Why?
|
| Pulmonary Veins | 1 | 2014 | 167 | 0.090 |
Why?
|
| Stromal Cells | 1 | 2014 | 316 | 0.090 |
Why?
|
| Diet, High-Fat | 1 | 2014 | 268 | 0.090 |
Why?
|
| Estradiol | 1 | 2014 | 460 | 0.090 |
Why?
|
| Microarray Analysis | 1 | 2012 | 223 | 0.090 |
Why?
|
| Forkhead Transcription Factors | 1 | 2014 | 373 | 0.090 |
Why?
|
| Eating | 1 | 2014 | 374 | 0.090 |
Why?
|
| Hormones | 1 | 2012 | 162 | 0.090 |
Why?
|
| Protein Carbonylation | 1 | 2010 | 6 | 0.080 |
Why?
|
| Palmitic Acid | 1 | 2010 | 27 | 0.080 |
Why?
|
| Young Adult | 2 | 2017 | 9990 | 0.080 |
Why?
|
| Infant | 4 | 2022 | 13264 | 0.080 |
Why?
|
| Lipid Peroxidation | 1 | 2010 | 92 | 0.080 |
Why?
|
| Anti-Obesity Agents | 1 | 2010 | 48 | 0.080 |
Why?
|
| Estrogen Receptor alpha | 1 | 2014 | 426 | 0.080 |
Why?
|
| Single-Blind Method | 1 | 2010 | 234 | 0.080 |
Why?
|
| Emulsions | 2 | 2021 | 69 | 0.080 |
Why?
|
| Soybean Oil | 2 | 2021 | 71 | 0.080 |
Why?
|
| Fish Oils | 2 | 2021 | 82 | 0.080 |
Why?
|
| Hexoses | 1 | 2009 | 10 | 0.080 |
Why?
|
| Ketone Bodies | 1 | 2009 | 41 | 0.080 |
Why?
|
| Calorimetry, Indirect | 1 | 2009 | 64 | 0.070 |
Why?
|
| Lactates | 1 | 2009 | 81 | 0.070 |
Why?
|
| Glucagon | 1 | 2009 | 145 | 0.070 |
Why?
|
| Fatty Acids, Nonesterified | 1 | 2009 | 112 | 0.070 |
Why?
|
| Nuclear Proteins | 1 | 2015 | 1206 | 0.070 |
Why?
|
| C-Peptide | 1 | 2009 | 105 | 0.070 |
Why?
|
| Diet, Reducing | 1 | 2009 | 91 | 0.070 |
Why?
|
| Dietary Proteins | 1 | 2009 | 222 | 0.060 |
Why?
|
| Models, Biological | 1 | 2012 | 1375 | 0.060 |
Why?
|
| Urea | 2 | 2018 | 219 | 0.060 |
Why?
|
| Breath Tests | 1 | 2007 | 182 | 0.060 |
Why?
|
| Yogurt | 1 | 2006 | 13 | 0.060 |
Why?
|
| Body Height | 1 | 2007 | 192 | 0.060 |
Why?
|
| Vitamin B 12 Deficiency | 1 | 2006 | 43 | 0.060 |
Why?
|
| Energy Intake | 1 | 2009 | 501 | 0.060 |
Why?
|
| Texas | 1 | 2015 | 3651 | 0.060 |
Why?
|
| Lung | 1 | 2014 | 1532 | 0.060 |
Why?
|
| Liver | 3 | 2019 | 1788 | 0.060 |
Why?
|
| Transcription Factors | 1 | 2015 | 2402 | 0.060 |
Why?
|
| Chi-Square Distribution | 1 | 2006 | 563 | 0.060 |
Why?
|
| Mechanistic Target of Rapamycin Complex 1 | 1 | 2025 | 178 | 0.060 |
Why?
|
| Administration, Intravenous | 1 | 2025 | 172 | 0.060 |
Why?
|
| Promoter Regions, Genetic | 2 | 2021 | 1209 | 0.050 |
Why?
|
| Oxidative Stress | 2 | 2020 | 793 | 0.050 |
Why?
|
| Adrenergic beta-3 Receptor Agonists | 1 | 2024 | 6 | 0.050 |
Why?
|
| Infant Formula | 1 | 2025 | 105 | 0.050 |
Why?
|
| Dioxoles | 1 | 2024 | 13 | 0.050 |
Why?
|
| Mutation | 1 | 2018 | 6069 | 0.050 |
Why?
|
| Uncoupling Protein 1 | 1 | 2024 | 33 | 0.050 |
Why?
|
| Cell Line, Tumor | 2 | 2022 | 3712 | 0.050 |
Why?
|
| Amino Acids, Branched-Chain | 1 | 2024 | 74 | 0.050 |
Why?
|
| Body Weight | 1 | 2007 | 985 | 0.050 |
Why?
|
| Glutamic Acid | 1 | 2024 | 192 | 0.050 |
Why?
|
| Infant, Newborn | 3 | 2025 | 8549 | 0.050 |
Why?
|
| Gene Expression | 2 | 2019 | 1480 | 0.050 |
Why?
|
| Lipopolysaccharides | 1 | 2024 | 300 | 0.050 |
Why?
|
| Sex Factors | 2 | 2017 | 1339 | 0.050 |
Why?
|
| Algorithms | 1 | 2009 | 1661 | 0.050 |
Why?
|
| Glycosyltransferases | 1 | 2022 | 26 | 0.050 |
Why?
|
| Fucosyltransferases | 1 | 2021 | 25 | 0.040 |
Why?
|
| Glycosylation | 1 | 2021 | 127 | 0.040 |
Why?
|
| Mucins | 1 | 2021 | 71 | 0.040 |
Why?
|
| ARNTL Transcription Factors | 1 | 2021 | 45 | 0.040 |
Why?
|
| Gene Knockout Techniques | 1 | 2021 | 132 | 0.040 |
Why?
|
| Spores, Bacterial | 1 | 2020 | 23 | 0.040 |
Why?
|
| Gangliosides | 1 | 2021 | 71 | 0.040 |
Why?
|
| Benzamides | 1 | 2021 | 125 | 0.040 |
Why?
|
| Erythropoietin | 1 | 2021 | 102 | 0.040 |
Why?
|
| Fluorocarbons | 1 | 2021 | 66 | 0.040 |
Why?
|
| Fat Emulsions, Intravenous | 1 | 2021 | 81 | 0.040 |
Why?
|
| Prevalence | 1 | 2007 | 2687 | 0.040 |
Why?
|
| Drug Synergism | 1 | 2020 | 236 | 0.040 |
Why?
|
| Cluster Analysis | 1 | 2021 | 412 | 0.040 |
Why?
|
| Adolescent | 2 | 2024 | 20808 | 0.040 |
Why?
|
| Alanine Transaminase | 1 | 2020 | 153 | 0.040 |
Why?
|
| Olive Oil | 1 | 2019 | 24 | 0.040 |
Why?
|
| Fatty Liver, Alcoholic | 1 | 2019 | 2 | 0.040 |
Why?
|
| Tight Junction Proteins | 1 | 2019 | 14 | 0.040 |
Why?
|
| Fatty Acid Transport Proteins | 1 | 2019 | 11 | 0.040 |
Why?
|
| Aldehydes | 1 | 2019 | 27 | 0.040 |
Why?
|
| Cell Survival | 1 | 2021 | 831 | 0.040 |
Why?
|
| Nutritional Status | 1 | 2020 | 297 | 0.040 |
Why?
|
| Fermentation | 1 | 2019 | 66 | 0.040 |
Why?
|
| Fatty Acids, Volatile | 1 | 2019 | 43 | 0.040 |
Why?
|
| Tissue Culture Techniques | 1 | 2018 | 63 | 0.030 |
Why?
|
| Argininosuccinate Synthase | 1 | 2018 | 25 | 0.030 |
Why?
|
| Vasomotor System | 1 | 2018 | 19 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2007 | 3777 | 0.030 |
Why?
|
| Mice, Inbred ICR | 1 | 2018 | 137 | 0.030 |
Why?
|
| Ornithine Carbamoyltransferase Deficiency Disease | 1 | 2018 | 42 | 0.030 |
Why?
|
| Cytokines | 1 | 2024 | 1336 | 0.030 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2021 | 1000 | 0.030 |
Why?
|
| Mice, Mutant Strains | 1 | 2018 | 354 | 0.030 |
Why?
|
| Dysbiosis | 1 | 2019 | 144 | 0.030 |
Why?
|
| Organoids | 1 | 2020 | 298 | 0.030 |
Why?
|
| Nitrogen | 1 | 2017 | 120 | 0.030 |
Why?
|
| Weaning | 1 | 2017 | 52 | 0.030 |
Why?
|
| Healthy Volunteers | 1 | 2017 | 152 | 0.030 |
Why?
|
| Inflammation | 1 | 2024 | 1480 | 0.030 |
Why?
|
| Random Allocation | 1 | 2017 | 409 | 0.030 |
Why?
|
| Body Composition | 1 | 2019 | 541 | 0.030 |
Why?
|
| Child | 2 | 2007 | 26179 | 0.030 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2019 | 637 | 0.030 |
Why?
|
| Colon | 1 | 2019 | 363 | 0.030 |
Why?
|
| Longitudinal Studies | 1 | 2020 | 1483 | 0.030 |
Why?
|
| Diet, Western | 1 | 2015 | 20 | 0.030 |
Why?
|
| Chronic Disease | 1 | 2020 | 1240 | 0.030 |
Why?
|
| Carbohydrate Metabolism | 1 | 2015 | 50 | 0.030 |
Why?
|
| Feces | 1 | 2019 | 718 | 0.030 |
Why?
|
| Mitogens | 1 | 2014 | 30 | 0.030 |
Why?
|
| Primary Cell Culture | 1 | 2014 | 105 | 0.030 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2015 | 196 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2015 | 1013 | 0.020 |
Why?
|
| Oxygen Consumption | 1 | 2014 | 295 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2015 | 1205 | 0.020 |
Why?
|
| Risk Factors | 1 | 2007 | 10955 | 0.020 |
Why?
|
| Weight Gain | 1 | 2015 | 384 | 0.020 |
Why?
|
| Cellular Reprogramming | 1 | 2014 | 127 | 0.020 |
Why?
|
| Adipose Tissue | 1 | 2015 | 497 | 0.020 |
Why?
|
| Alternative Splicing | 1 | 2014 | 310 | 0.020 |
Why?
|
| Heterozygote | 1 | 2014 | 722 | 0.020 |
Why?
|
| Biomarkers | 1 | 2021 | 3355 | 0.020 |
Why?
|
| Estrogens | 1 | 2014 | 426 | 0.020 |
Why?
|
| Antineoplastic Agents | 1 | 2021 | 1802 | 0.020 |
Why?
|
| Endometrium | 1 | 2014 | 286 | 0.020 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2019 | 830 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2006 | 12837 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2015 | 2329 | 0.020 |
Why?
|
| Transcription, Genetic | 1 | 2014 | 1364 | 0.020 |
Why?
|
| Anti-Bacterial Agents | 1 | 2020 | 2569 | 0.020 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2013 | 890 | 0.020 |
Why?
|
| Brain | 1 | 2019 | 3146 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2014 | 2460 | 0.020 |
Why?
|
| Middle Aged | 1 | 2017 | 28315 | 0.010 |
Why?
|